Dupont De Nemours, Inc. (DD) Stock Price & Analysis
Dupont De Nemours, Inc. (DD) rose 0.22% to USD 137.7 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
DD last closed at USD 137.4; the session ranged USD 137.08–138.94 on volume of 605,032 shares. Market capitalization is —, with a 52-week range of USD 86.59–157.98 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 137.7 |
|---|---|
| Change | ▲ 0.22% (up) |
| Previous Close | USD 137.4 |
| Open | USD 137.81 |
| Day Range | USD 137.08 – 138.94 |
| 52-Week Range | USD 86.59 – 157.98 |
| Volume | 605,032 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (DD)
Nexqual's technical model rates DD "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.29 (neutral) |
| vs SMA50 | Below (USD 140.73) |
| MACD | -0.85 (negative) |
Analyst Ratings (DD)
Wall Street analysts rate DD "Buy" based on 16 analysts, with a mean price target of USD 169.63 (range USD 153–186), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 169.63 |
| High Target | USD 186 |
| Low Target | USD 153 |
| Buy / Hold / Sell | 14 / 3 / 0 |
Earnings (DD)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 1.68 |
| Revenue Estimate | $1.81B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.65 vs est 1.45 ▲ beat |
| 2025-12-31 | USD 1.38 vs est 1.29 ▲ beat |
| 2025-09-30 | USD 3.27 vs est 2.94 ▲ beat |
| 2025-06-30 | USD 3.36 vs est 3.18 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (DD)
| Total Revenue | $6.92B |
|---|---|
| Revenue Growth (YoY) | +4.30% |
| Gross Margin | +35.01% |
| Operating Margin | +13.80% |
| Profit Margin | -0.42% |
| ROE | +0.90% |
| Debt / Equity | 22.59 |
| Current Ratio | 2.68 |
| Total Cash | $710.00M |
| Total Debt | $3.22B |
| Free Cash Flow | $-124.75M |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (DD)
Nexqual rates Dupont De Nemours, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Mixed — Revenue +4.3% YoY (latest Q), slow |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 14% |
| Balance Sheet | Strong — $710M cash vs $3.22B debt |
| Cash Flow | Weak — FCF negative: -$125M, burning cash |
| Efficiency | Weak — ROE 1%, ROA 2.0% |
Ownership (DD)
| Insider Ownership | +0.19% |
|---|---|
| Institutional Ownership | +78.18% |
| Float | 136.07M |
| Short % of Float | +4.88% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Leadership (DD)
Dupont De Nemours, Inc. is led by Lori D. Koch (age 50), CEO & Director, per Nexqual as of July 25, 2026 at 01:12 UTC.
| CEO & Director | Lori D. Koch (age 50) |
|---|---|
| Senior VP & CFO | Antonella B. Franzen (age 49) |
| President of Healthcare & Water Technologies | Jeroen Bloemhard (age 56) |
| Chief Technology Officer | Marty DeGroot |
Major Backers & Investors (DD)
Notable institutional backers of Dupont De Nemours, Inc. include Invesco, Morgan Stanley, Victory Capital Management Inc., according to Nexqual as of July 25, 2026 at 01:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 3.94% |
| Morgan Stanley | 2.01% |
| Victory Capital Management Inc. | 1.55% |
| Fidelity | 1.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.92% |
| BlackRock | 9.02% |
| State Street | 5.85% |
| Geode Capital | 2.75% |
| Nuveen | 1.61% |
| Northern Trust | 1.29% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Dupont De Nemours, Inc.'s Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
- It operates through two segments, Healthcare & Water Technologies and Diversified Industrials.
- The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors.
- It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOW | Dow Inc. | USD 29.84 | ▼ 4.51% |
| MMM | 3M Company | USD 172.62 | ▲ 1.09% |
| AA | Alcoa Corporation | USD 44.24 | ▼ 4.18% |
| HON | Honeywell International Inc. | USD 243.15 | ▲ 4.36% |
| CAT | Caterpillar, Inc. | USD 888.73 | ▼ 0.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.